technetium 99m has been researched along with Amyloidosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Carpinteiro, A; Fragoso Costa, P; Hagenacker, T; Herrmann, K; Jentzen, W; Kersting, D; Kessler, L; Lüdike, P; Oubari, S; Papathanasiou, M; Rassaf, T; Rischpler, C; Thimm, A; Weber, M | 1 |
| Choi, JO; Choi, JY; Kim, D; Kim, K; Kim, SJ; Lee, J; Park, YJ | 1 |
| Angelotti, P; Bartolini, S; Cappelli, F; Ciaccio, A; Costanzo, EN; Di Mario, C; Frusconi, S; Gallini, C; Martone, R; Morini, S; Perfetto, F; Tutino, F; Vaggelli, L | 1 |
3 other study(ies) available for technetium 99m and Amyloidosis
| Article | Year |
|---|---|
Quantitative
Topics: Amyloidosis; Cardiomyopathies; Heart; Humans; Prealbumin; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2023 |
Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.
Topics: Amyloidosis; Cardiomyopathies; Heart; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Technetium Tc 99m Pyrophosphate | 2023 |
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon.
Topics: Aged; Aged, 80 and over; Amyloidosis; Female; Humans; Hypertrophy, Left Ventricular; Lung; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium; Whole Body Imaging | 2018 |